| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 121-124 |
| Número de páginas | 4 |
| Publicación | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders |
| Volumen | 5 |
| N.º | SUPPL. 1 |
| DOI | |
| Estado | Published - sept 2004 |
Nota bibliográfica
Funding Information:The Phase III clinical trial of minocycline has been funded by the National Institutes of Health and the Muscular Dystrophy Association and this study is now underway at 31 centers under the direction of Dr. Paul Gordon at Columbia University, New York.
Financiación
The Phase III clinical trial of minocycline has been funded by the National Institutes of Health and the Muscular Dystrophy Association and this study is now underway at 31 centers under the direction of Dr. Paul Gordon at Columbia University, New York.
| Financiadores |
|---|
| National Institutes of Health (NIH) |
| Muscular Dystrophy Association |
ASJC Scopus subject areas
- Clinical Neurology
Huella
Profundice en los temas de investigación de 'Western ALS study group'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver